RECRUITING

STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this nationwide study is to test STELLA-FTD (Support via Telehealth: Living and Learning with Advancing Alzheimer's Disease)-FTD, an intervention to specifically address the needs of family Care Partners of persons with frontotemporal degeneration (FTD). STELLA-FTD is a multicomponent videoconference-based intervention designed to facilitate effective use of community and peer resources to foster effective management of behavioral and psychological symptoms of dementia. The study is recruiting families from across the United States.

Official Title

STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners

Quick Facts

Study Start:2025-06-23
Study Completion:2029-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06613204

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 100 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult caring for family member with FTD.
  2. * Provides 4 or more hours of care/week. Does not have to reside with.
  3. * Identifies at least 2 moderately upsetting behaviors in the person with FTD.
  4. * Speaks and understands English to be able to participate in intervention.
  5. * Owns a telephone (smartphone, cell phone or landline).
  6. * Has email and mailing address to receive computer, study materials and surveys.
  7. * Provides informed consent to participate in the research.
  8. * Lives in the US
  1. * No Frontotemporal Degeneration diagnosis.
  2. * Unable to leave Care Partner during STELLA-FTD sessions.
  3. * Enrolled in hospice.

Contacts and Locations

Study Contact

Hailey Chatterton, MS
CONTACT
503-568-9725
chatterton@ohsu.edu
Allison Lindauer, PhD, APRN
CONTACT
503-494-6976
lindauer@ohsu.edu

Principal Investigator

Allison Lindauer, PhD, APRN
PRINCIPAL_INVESTIGATOR
Oregon Health and Science University
Aimee Mooney, MA, CCC-SLP
STUDY_DIRECTOR
Oregon Health and Science University

Study Locations (Sites)

Oregon Health & Science University
Portland, Oregon, 97239
United States

Collaborators and Investigators

Sponsor: Oregon Health and Science University

  • Allison Lindauer, PhD, APRN, PRINCIPAL_INVESTIGATOR, Oregon Health and Science University
  • Aimee Mooney, MA, CCC-SLP, STUDY_DIRECTOR, Oregon Health and Science University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-06-23
Study Completion Date2029-06

Study Record Updates

Study Start Date2025-06-23
Study Completion Date2029-06

Terms related to this study

Keywords Provided by Researchers

  • behavioral intervention
  • FTD

Additional Relevant MeSH Terms

  • Frontotemporal Dementia
  • Caregiver Burden
  • Primary Progressive Aphasia (PPA)
  • Corticobasal Syndrome